Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Cosmi

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Biomedicines|November 11, 2022
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life ExperienceAndrea Matucci, Emanuele Vivarelli, Margherita Perlato, et al.
The Journal of Allergy and Clinical Immunology|July 3, 2007
Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individualsLaura Maggi, Veronica Santarlasci, Francesco Liotta, et al.
Biomedicines|March 29, 2023
EGPA Phenotyping: Not Only ANCA, but Also EosinophilsAndrea Matucci, Emanuele Vivarelli, Margherita Perlato, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2003
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cellsFrancesca Brugnolo, Salvatore Sampognaro, Francesco Liotta, et al.
Clinical and Molecular Allergy : CMA|July 24, 2015
Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenarioFrancesco Giudici, Laura Maggi, Raffaella Santi, et al.
International Archives of Allergy and Immunology|December 22, 2012
CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapyLaura Maggi, Manuela Capone, Francesco Giudici, et al.
Rheumatology and Immunology Research|July 3, 2025
Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treatedGiulia Micheli, Lorenzo Salvati, Boaz Palterer, et al.
Frontiers in Immunology|March 25, 2026
Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapyLorenzo Salvati, Manuela Capone, Alessio Mazzoni, et al.
Allergy|October 4, 2023
Blood CD62L<sup>low</sup> inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumabAlessandra Vultaggio, Matteo Accinno, Emanuele Vivarelli, et al.
Blood|November 6, 2009
Evidence for a cross-talk between human neutrophils and Th17 cellsMartin Pelletier, Laura Maggi, Alessandra Micheletti, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Biomedicines|November 11, 2022
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life ExperienceAndrea Matucci, Emanuele Vivarelli, Margherita Perlato, et al.
The Journal of Allergy and Clinical Immunology|July 3, 2007
Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individualsLaura Maggi, Veronica Santarlasci, Francesco Liotta, et al.
Biomedicines|March 29, 2023
EGPA Phenotyping: Not Only ANCA, but Also EosinophilsAndrea Matucci, Emanuele Vivarelli, Margherita Perlato, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2003
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cellsFrancesca Brugnolo, Salvatore Sampognaro, Francesco Liotta, et al.
Clinical and Molecular Allergy : CMA|July 24, 2015
Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenarioFrancesco Giudici, Laura Maggi, Raffaella Santi, et al.
International Archives of Allergy and Immunology|December 22, 2012
CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapyLaura Maggi, Manuela Capone, Francesco Giudici, et al.
Rheumatology and Immunology Research|July 3, 2025
Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treatedGiulia Micheli, Lorenzo Salvati, Boaz Palterer, et al.
Frontiers in Immunology|March 25, 2026
Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapyLorenzo Salvati, Manuela Capone, Alessio Mazzoni, et al.
Allergy|October 4, 2023
Blood CD62L<sup>low</sup> inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumabAlessandra Vultaggio, Matteo Accinno, Emanuele Vivarelli, et al.
Blood|November 6, 2009
Evidence for a cross-talk between human neutrophils and Th17 cellsMartin Pelletier, Laura Maggi, Alessandra Micheletti, et al.
Pageof 14